Recent South African Trial Reveals J&J's 'High Effectiveness' Against Delta Strain The clinical trial in South Africa revealed that the Johnson & Johnson vaccine can combat the Delta variant at 71% effectivity. by Joseph Henry
Health FDA Advises People to Stop Using J&J Vaccine Due to Blood Clotting: What Vaccinated Individuals Should Do by Giuliano J. de Leon